Navigation Links
Older Mothers Pass on Infertility Risk to their Daughters

Women who put off having children until later in life risk passing on an infertility risk to their daughters, researchers warned yesterday. This discovery is the first// evidence that the reduced fertility seen in older women causes genetic damage which is passed on at the time that they conceive, to their female children, causing reduced fertility in them.

According to doctors behind the study while it was still too early to predict the impact of the effect, they suggested that the trend for couples to put off starting families until their mid-30s and beyond will gradually cause many young women to seek for fertility treatment simply because they were born to older mothers. Details of the research were announced at the American Society of Reproductive Medicine in New Orleans yesterday.

Lead researcher, Peter Nagy, of Reproductive Biology Associates in Atlanta, selected 74 women attending the fertility clinic and asked them about their parents' ages when they were born and the ages at which their mothers reached the menopause. Following this the women were divided into two groups, one group of those who had successful pregnancies, and the other of those who failed to become pregnant.

The study revealed that women who became pregnant had on average comparatively younger parents, with fathers aged 28.2 and mothers aged 25.7, while women who failed to get pregnant were found to have parents whose average ages were 31.9 and 28.2.

On further examination of the figures the researchers found that women who failed to conceive were born to mothers who were on average five years closer to the menopause. They were born when their mothers were an average of 19.6 years away from the menopause, compared with 24.7 years for women who did get pregnant. The age of the women's fathers had no significant effect.

The age of menopause is typically around 50. The researcher’s studies revealed that the nearer a woman is to menopause when s
'"/>




Page: 1 2

Related medicine news :

1. Older men father schizophrenics
2. Creatine Helps Strengthen Older Men
3. Older Men Surviving Coronary Bypasses
4. Older womens heart health depends on location of fat
5. Older Breast Cancer Patients Can Be Effectively Treated With Chemotherapy
6. Frailty in Older Women may be due to Chronic Infection
7. Withdrawal Notice Issued For Older Pacemakers Due To Malfunctioning of the Device
8. Older People May Not Need Multivitamins To Prevent Infections
9. Gene Variation Associated With Better Mobility For Older Individuals
10. Older People Can Also Eat As Young!
11. Safe Driving Is Possible For Older People If They Are Prepared
Post Your Comments:
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2
...icials across UK are participating in a dummy exer...y bird flu pandemic. The preparation may be s...n Britain are wary of a bird flu epidemic hitting ... chiefly in birds, but infections with these virus...
...s have developed an experimental vaccine that redu...d with cytomegalovirus// (CMV). This virus also ca...n children infected in early fetal life. The Natio... no vaccine or treatment for pregnant women who ha...
...er Anoushka Shankar has become the first Indian ce...o fight against hunger in India//. She joins...ollywood star Drew Barrymore and footballer Ronald...ause. I will personally do whatever I can to raise...
... a haven for migratory birds, is gearing up to tac...ases// of the deadly virus. "We are watching...industry to take certain protective measures," sai...lu had been reported yet from any part of the stat...
...ounterfeit drugs are being circulated in South Asi...ingitis, typhoid//, pneumonia and avian flu. Accor...iane, the drugs have been well disguised making it... treated with the original drug. They also add tha...
...to a report released by International Federation o...a has been hit by measles//. This disease has so f...people are said to be affected by this illness. ... cases pointing to the spread of the disease. The ...
Other Medicine News:Health News:Dummy Emergency Operation Launched 2Health News:CMV Vaccine Prototype Successfully Tested in Guinea Pigs 2Health News:CMV Vaccine Prototype Successfully Tested in Guinea Pigs 3
(Date:12/3/2009)SUNNYVALE, Calif., Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune media
(Date:12/3/2009)WARRENDALE, Pa., Dec. 3 Radiology imaging leader MEDRAD, Inc. demonstrated PACS* injection-record integration capabilities at the November 2009 Radiology Society of North America in Chicago. The Co
(Date:12/3/2009)FORT WORTH, Texas, Dec. 3 Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), a rapidly growing provider of specialty medical products, announced today an agreement with the Health In
Breaking Medicine Technology:Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3West Announces Third Quarter 2009 Results 5943 1West Announces Third Quarter 2009 Results 5943 2West Announces Third Quarter 2009 Results 5943 3West Announces Third Quarter 2009 Results 5943 4West Announces Third Quarter 2009 Results 5943 5West Announces Third Quarter 2009 Results 5943 6West Announces Third Quarter 2009 Results 5943 7West Announces Third Quarter 2009 Results 5943 8West Announces Third Quarter 2009 Results 5943 9West Announces Third Quarter 2009 Results 5943 10West Announces Third Quarter 2009 Results 5943 11West Announces Third Quarter 2009 Results 5943 12West Announces Third Quarter 2009 Results 5943 13West Announces Third Quarter 2009 Results 5943 14West Announces Third Quarter 2009 Results 5943 15West Announces Third Quarter 2009 Results 5943 16West Announces Third Quarter 2009 Results 5943 17West Announces Third Quarter 2009 Results 5943 18West Announces Third Quarter 2009 Results 5943 19West Announces Third Quarter 2009 Results 5943 20West Announces Third Quarter 2009 Results 5943 21West Announces Third Quarter 2009 Results 5943 22Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 1Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 2Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 3Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 4Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 5Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 6Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 7Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 8Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 9Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 10Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 11Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 12Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 13Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 14Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 15Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 16Experimental Stem Cell Therapy Raises Hope for Pulmonary Fibrosis Patients 14698 1Experimental Stem Cell Therapy Raises Hope for Pulmonary Fibrosis Patients 14698 2Experimental Stem Cell Therapy Raises Hope for Pulmonary Fibrosis Patients 14698 3
...48-week investigational regimen yielded nearly dou...ate on next-generation HCV protease inhibitor SCH ...HAGEN, Denmark, April 23 Schering-Plough Corporat...ts of the HCV SPRINT-1 study showed boceprevir, it...tor, in combination with peginterferon alfa-2b and...
... , , , FDA approval for testing in humans water..., , ROCKVILLE, Md., April 23 In a move that high...n in tackling international health challenges, the... from the PATH Malaria Vaccine Initiative (MVI), h... tests in adult volunteers -- of its unique malari...
Other Medicine Technology:Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 2Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 3Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 4Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 5Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 6Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 7Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 8Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 9Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 10Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 11Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 12Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin 2Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin 3Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin 4
...G-9200 is a Windows 2000 PC based EEG with high pe... and software. EEG-9200 provides high quality perf...in the sleep lab or EEG lab. Quality EEG recording...CU. Neurofax has high performance, high sensitivit...
...act is the first magnetic stimulator to offer the ... stimulation. It is designed to provide the simple...tic routine (at the same time, it may also help re...ons without moving away from your patient). , ,...
Fidelity IAB Intra-Aortic Balloon Catheter
...series is a new top-line range of digital pacemake...rillation (AF). Because the T-series combines digi...reatment of AF is taken one step further. Thanks t...ored continuously and extensively. This gives phys...
Medicine Products: